Skip to main content

Date last updated: 01/19/2021

 

General comments:  We provide these summary data in the spirit of transparency and open data sharing.  Given the relatively small number of reported cases and preliminary nature of these reports, we do not recommend these data be used to inform clinical decisions at this time. Additionally, as many mild cases of COVID-19 do not undergo testing, these data may over-represent more severe cases in which COVID-19 testing was performed. Please note that rows and columns from tables below may not add up to the exact number of total reported cases due to incomplete data and/or non-mutually exclusive variables.

Please use the following citation if referencing the data on this page: Brenner EJ, Ungaro RC, Colombel JF, Kappelman MD. SECURE-IBD Database Public Data Update. covidibd.org. Accessed on MM/DD/YY.

 

Total number of cases reported: 4,578

 

Report a Case

Cases reported by country*

countryN
United States1798
United Arab Emirates15
Afghanistan1
Argentina70
Austria69
Australia11
Belgium154
Bulgaria16
Bahrain1
Saint Barthélemy1
Bolivia, Plurinational State of1
Brazil116
Canada93
Switzerland39
Chile22
China1
Colombia3
Costa Rica4
Cyprus4
Czech Republic38
Germany118
Dominican Republic14
Ecuador1
Egypt2
Spain333
Finland7
France119
United Kingdom194
Greece25
Croatia15
Hungary3
Ireland58
Israel42
India34
Iran, Islamic Republic of58
Italy174
Japan23
Korea, Republic of1
Kuwait17
Kazakhstan1
Luxembourg1
Morocco7
Mexico13
Malaysia2
Netherlands204
Norway14
New Zealand1
Peru9
Poland26
Portugal68
Paraguay1
Qatar2
Romania15
Serbia13
Russian Federation285
Saudi Arabia14
Sweden2
Slovenia15
Slovakia28
Tunisia2
Turkey80
Ukraine1
Uruguay1
Venezuela, Bolivarian Republic of4
South Africa17
Missing57

* Countries not included in this table have not reported any cases to SECURE-IBD

 

Cases reported by state (U.S. only)*

stateN
ALABAMA22
ARIZONA18
ARKANSAS9
CALIFORNIA95
COLORADO12
CONNECTICUT26
DELAWARE4
DISTRICT OF COLUMBIA8
FLORIDA68
GEORGIA51
IDAHO2
ILLINOIS160
INDIANA14
IOWA19
KANSAS15
KENTUCKY13
LOUISIANA42
MAINE2
MARYLAND29
MASSACHUSETTS52
MICHIGAN31
MINNESOTA60
MISSISSIPPI23
MISSOURI41
MONTANA7
NEBRASKA45
NEVADA6
NEW HAMPSHIRE3
NEW JERSEY58
NEW MEXICO1
NEW YORK264
NORTH CAROLINA46
NORTH DAKOTA3
OHIO107
OKLAHOMA8
OREGON6
PENNSYLVANIA75
RHODE ISLAND20
SOUTH CAROLINA14
SOUTH DAKOTA2
TENNESSEE59
TEXAS80
UTAH16
VERMONT2
VIRGINIA28
WASHINGTON24
WEST VIRGINIA1
WISCONSIN56
GUAM1
PUERTO RICO2
NA48

* States not included in this table have not reported any cases to SECURE-IBD

 

Cases and outcomes by patient characteristics

CharacteristicTotal NOutpatient only (n, %)Hospitalized (n, %)ICU (n, %)Ventilator (n, %)Death (n, %)ICU/Ventilator/Death (n, %)
Overall4,5783,73582%78317%1473%1112%782%2024%
Age
0-9 years 292690%27%27%27%00%27%
10-19 years 45943394%235%31%10%00%31%
20-29 years 98889290%838%40%10%10%51%
30-39 years 94982487%10811%141%71%30%152%
40-49 years 80166583%13116%213%152%20%233%
50-59 years 68451575%16424%355%304%112%446%
60-69 years 38023061%14137%4412%349%205%5214%
70-79 years 1578051%7346%1912%149%1811%3120%
>=80 years 1085147%5450%33%76%2220%2523%
Sex
Male 2,2021,75180%42619%753%563%522%1105%
Female 2,3031,92383%34715%693%522%261%894%
Other 3267%00%00%00%00%00%
Disease type
Crohn’s disease 2,6202,21585%37414%612%492%301%783%
Ulcerative Colitis/unspecified1,9311,49978%40521%844%603%472%1226%
IBD Disease
Activity
Remission2,5342,14385%37115%703%602%371%994%
Mild97481684%15015%242%162%162%364%
Moderate/Severe87563873%22526%445%283%202%566%
Unknown19513871%3719%95%74%53%116%
Smoking
Current smoker17413779%3721%53%21%42%74%
Non-smoker4,4043,59882%74617%1423%1092%742%1954%
Comorbidities
03,2352,85788%34411%421%321%80%522%
192769375%21523%404%293%232%536%
224612952%11346%2811%239%167%3916%
3+1705633%11165%3722%2716%3118%5834%
IBD medication
Sulfasalazine/mesalamine1,31797774%32625%645%574%413%937%
Budesonide 1198571%3328%76%33%33%87%
Oral/parenteral steroids 31319161%11637%3411%237%217%4414%
6MP/azathioprine monotherapy38329276%8823%226%144%82%287%
Methotrexate monotherapy362672%1028%13%13%13%26%
Anti-TNF without 6MP/AZA/MTX 1,5311,37190%1429%201%131%70%232%
Anti-TNF + 6MP/AZA/MTX 42434581%7518%123%72%31%154%
Anti-integrin 51943383%7615%183%102%71%245%
IL 12/23 inhibitor 43138389%389%61%51%20%72%
JAK inhibitor 716287%913%23%11%11%23%
Other IBD medication 14410674%3524%75%32%21%75%

*Medication categories are not mutually exclusive

 

Please use the following citation if referencing the data on this page: Brenner EJ, Ungaro RC, Colombel JF, Kappelman MD. SECURE-IBD Database Public Data Update. covidibd.org. Accessed on MM/DD/YY.